• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲型H1N1流感病毒神经氨酸酶抑制剂奥司他韦的计算机模拟修饰

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1.

作者信息

Tambunan Usman Sumo Friend, Rachmania Rizky Archintya, Parikesit Arli Aditya

机构信息

Bioinformatics Research Group, Department of Chemistry, Faculty of Mathematics and Natural Science, University of Indonesia, Depok Campus, Depok 16424, Indonesia.

出版信息

J Biomed Res. 2015 Apr;29(2):150-9. doi: 10.7555/JBR.29.20130024. Epub 2014 Dec 12.

DOI:10.7555/JBR.29.20130024
PMID:25859271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4389116/
Abstract

This research focused on the modification of the functional groups of oseltamivir as neuraminidase inhibitor against influenza A virus subtype H1N1. Interactions of three of the best ligands were evaluated in the hydrated state using molecular dynamics simulation at two different temperatures. The docking result showed that AD3BF2D ligand (N-[(1S,6R)-5-amino-5-{[(2R,3S,4S)-3,4-dihydroxy-4-(hydroxymethyl) tetrahydrofuran-2-yl]oxy}-4-formylcyclohex-3-en-1-yl]acetamide-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate) had better binding energy values than standard oseltamivir. AD3BF2D had several interactions, including hydrogen bonds, with the residues in the catalytic site of neuraminidase as identified by molecular dynamics simulation. The results showed that AD3BF2D ligand can be used as a good candidate for neuraminidase inhibitor to cope with influenza A virus subtype H1N1.

摘要

本研究聚焦于对作为甲型H1N1流感病毒神经氨酸酶抑制剂的奥司他韦官能团进行修饰。使用分子动力学模拟在两个不同温度下对三种最佳配体在水合状态下的相互作用进行了评估。对接结果表明,AD3BF2D配体(N-[(1S,6R)-5-氨基-5-{[(2R,3S,4S)-3,4-二羟基-4-(羟甲基)四氢呋喃-2-基]氧基}-4-甲酰基环己-3-烯-1-基]乙酰胺-3-(1-乙基丙氧基)-1-环己烯-1-羧酸酯)具有比标准奥司他韦更好的结合能值。通过分子动力学模拟确定,AD3BF2D与神经氨酸酶催化位点中的残基存在多种相互作用,包括氢键。结果表明,AD3BF2D配体可作为应对甲型H1N1流感病毒的神经氨酸酶抑制剂的良好候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/efdbaacf388a/jbr-29-02-150-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/90213d8fde92/jbr-29-02-150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/ae2f8933023c/jbr-29-02-150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/0c5ede8cd12a/jbr-29-02-150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/c733cb1ed0d4/jbr-29-02-150-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/54508c8e7051/jbr-29-02-150-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/9ed493bfffa5/jbr-29-02-150-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/efdbaacf388a/jbr-29-02-150-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/90213d8fde92/jbr-29-02-150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/ae2f8933023c/jbr-29-02-150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/0c5ede8cd12a/jbr-29-02-150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/c733cb1ed0d4/jbr-29-02-150-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/54508c8e7051/jbr-29-02-150-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/9ed493bfffa5/jbr-29-02-150-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6307/4389116/efdbaacf388a/jbr-29-02-150-g007.jpg

相似文献

1
In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1.甲型H1N1流感病毒神经氨酸酶抑制剂奥司他韦的计算机模拟修饰
J Biomed Res. 2015 Apr;29(2):150-9. doi: 10.7555/JBR.29.20130024. Epub 2014 Dec 12.
2
Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.酰基胍型奥司他韦羧酸盐衍生物作为强效神经氨酸酶抑制剂的发现。
Bioorg Med Chem. 2017 May 15;25(10):2772-2781. doi: 10.1016/j.bmc.2017.03.052. Epub 2017 Mar 27.
3
Kinetic, thermodynamic and structural analysis of tamiphosphor binding to neuraminidase of H1N1 (2009) pandemic influenza.kinetic, thermodynamic and structural analysis of tamiphosphor binding to neuraminidase of H1N1 (2009) pandemic influenza. kinetic、热力学和结构分析 of tamiphosphor 结合到 H1N1 (2009) 大流行流感的神经氨酸酶。
Eur J Med Chem. 2016 Oct 4;121:100-109. doi: 10.1016/j.ejmech.2016.05.016. Epub 2016 May 7.
4
In silico prediction of drug resistance due to S247R mutation of Influenza H1N1 neuraminidase protein.基于 S247R 突变的甲型 H1N1 流感神经氨酸酶蛋白的耐药性的计算机预测。
J Biomol Struct Dyn. 2018 Mar;36(4):966-980. doi: 10.1080/07391102.2017.1305295. Epub 2017 Apr 10.
5
Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.长时标 GPU 动力学揭示了 H1N1-2009 流感病毒双重突变体 I223R/H275Y 神经氨酸酶耐药机制。
Biochemistry. 2012 May 29;51(21):4364-75. doi: 10.1021/bi300561n. Epub 2012 May 17.
6
Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.同源建模、对接和分子动力学揭示 HR1039 是 2009 年 A(H1N1)流感神经氨酸酶的有效抑制剂。
Biophys Chem. 2010 Mar;147(1-2):74-80. doi: 10.1016/j.bpc.2009.12.002. Epub 2009 Dec 6.
7
Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.甲型流感病毒H1N1神经氨酸酶抑制剂奥司他韦衍生物的设计、计算机模拟研究、合成及体外评价
Eur J Med Chem. 2017 Mar 10;128:154-167. doi: 10.1016/j.ejmech.2017.01.039. Epub 2017 Jan 24.
8
The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.花色苷-3-桑布比定对 H1N1 流感病毒 H274Y 突变的抑制作用。
J Biomol Struct Dyn. 2018 Dec;36(16):4255-4269. doi: 10.1080/07391102.2017.1413422. Epub 2017 Dec 20.
9
Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.奥司他韦和扎那米韦治疗 H274Y 突变的甲型 H1N1 流感病毒的临床效果:2007-2008 年和 2008-2009 年流感季节的日本多中心研究。
Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.
10
Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.奥司他韦对 2009 年 A/H1N1 流感神经氨酸酶变异体敏感性的理论研究。
J Chem Inf Model. 2012 Oct 22;52(10):2715-29. doi: 10.1021/ci300375k. Epub 2012 Oct 2.

引用本文的文献

1
A Computational Study of Phenothiazine Derivatives as Acetylcholinesterase Inhibitors Targeting Alzheimer's Disease.以阿尔茨海默病为靶点的吩噻嗪衍生物作为乙酰胆碱酯酶抑制剂的计算研究
Cent Nerv Syst Agents Med Chem. 2025;25(1):68-82. doi: 10.2174/0118715249300784240430110628.
2
Implications of protein conformations to modifying novel inhibitor Oseltamivir for 2009 H1N1 influenza A virus by simulation and docking studies.通过模拟和对接研究探讨蛋白质构象对修饰新型甲型H1N1流感病毒抑制剂奥司他韦的影响。
Virusdisease. 2018 Dec;29(4):461-467. doi: 10.1007/s13337-018-0480-2. Epub 2018 Sep 1.
3
Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola.

本文引用的文献

1
A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites.一种评估异菌脲、腐霉利、乙烯菌核利及其代谢物雄激素亲和力的计算方法。
PLoS One. 2014 Aug 11;9(8):e104822. doi: 10.1371/journal.pone.0104822. eCollection 2014.
2
In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC).通过计算机模拟对琥珀酰亚胺基戊二酰胺(SAHA)进行修饰,以作为潜在的 II 类组蛋白去乙酰化酶(HDAC)抑制剂。
BMC Bioinformatics. 2011;12 Suppl 13(Suppl 13):S23. doi: 10.1186/1471-2105-12-S13-S23. Epub 2011 Nov 30.
3
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method.
基于柔性对接的天然产物化合物和埃博拉病毒核衣壳(EBOV NP)的分子动力学模拟:一种发现抗埃博拉新药物的计算方法。
BMC Bioinformatics. 2018 Nov 20;19(Suppl 14):419. doi: 10.1186/s12859-018-2387-8.
4
Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2.筛选β-OG口袋结合物类似物作为登革病毒2型的融合抑制剂
Drug Target Insights. 2015 Nov 16;9:33-49. doi: 10.4137/DTI.S31566. eCollection 2015.
通过核心跳跃法设计针对 H1N1 流感病毒的血凝素新型抑制剂。
PLoS One. 2011;6(11):e28111. doi: 10.1371/journal.pone.0028111. Epub 2011 Nov 30.
4
Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity.分子动力学方法估算 HIV-1 整合酶抑制剂的结合能,并与体外活性相关联。
Antimicrob Agents Chemother. 2012 Jan;56(1):411-9. doi: 10.1128/AAC.05292-11. Epub 2011 Oct 28.
5
Prediction of antimicrobial peptides based on sequence alignment and feature selection methods.基于序列比对和特征选择方法的抗菌肽预测。
PLoS One. 2011 Apr 13;6(4):e18476. doi: 10.1371/journal.pone.0018476.
6
Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virus.三种新型强效奥司他韦衍生物抑制流感病毒神经氨酸酶。
Biochem Biophys Res Commun. 2010 Oct 15;401(2):188-91. doi: 10.1016/j.bbrc.2010.09.020. Epub 2010 Sep 16.
7
The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter.三环类抗抑郁药的高亲和力结合位点位于 5-羟色胺转运体的外腔室。
Mol Pharmacol. 2010 Dec;78(6):1026-35. doi: 10.1124/mol.110.067538. Epub 2010 Sep 9.
8
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses.扎那米韦类似物,其 C4-取代基经修饰,作为抗流感病毒组 1 神经氨酸酶抑制剂。
Bioorg Med Chem. 2010 Jun 1;18(11):4074-84. doi: 10.1016/j.bmc.2010.04.010. Epub 2010 Apr 8.
9
Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis.从甘草根部分离得到的多酚化合物对神经氨酸酶活性的抑制作用。
Bioorg Med Chem Lett. 2010 Feb 1;20(3):971-4. doi: 10.1016/j.bmcl.2009.12.106. Epub 2010 Jan 4.
10
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.探究奥司他韦(达菲)与2009年甲型H1N1流感病毒神经氨酸酶相互作用的见解。
Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.